Moderna (Germany) Today
| 0QF Stock | EUR 40.00 1.71 4.10% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Moderna is trading at 40.00 as of the 27th of November 2024. This is a 4.1 percent decrease since the beginning of the trading day. The stock's lowest day price was 39.75. Moderna has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Moderna are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. The company has 385 M outstanding shares. More on Moderna
Moving together with Moderna Stock
| 0.9 | NOVA | Novo Nordisk AS | PairCorr |
| 0.7 | CSJA | CSL LTD SPONADR | PairCorr |
| 0.73 | CSJ | CSL Limited | PairCorr |
| 0.83 | MBG | Mercedes Benz Group | PairCorr |
Moving against Moderna Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Moderna Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Moderna's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Moderna or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Stephane Bancel |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Moderna (0QF) is traded on Frankfurt Exchange in Germany and employs 3,900 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 50.28 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Moderna's market, we take the total number of its shares issued and multiply it by Moderna's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Moderna classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 385 M outstanding shares.
Moderna has accumulated about 7.99 B in cash with 4.98 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.8.
Check Moderna Probability Of Bankruptcy
Ownership AllocationModerna maintains a total of 385 Million outstanding shares. Over half of Moderna's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Moderna. Please watch out for any change in the institutional holdings of Moderna as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Moderna Ownership Details
Moderna Risk Profiles
Although Moderna's alpha and beta are two of the key measurements used to evaluate Moderna's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.44 | |||
| Standard Deviation | 3.4 | |||
| Variance | 11.55 | |||
| Risk Adjusted Performance | (0.17) |
Moderna Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Moderna without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Moderna Corporate Management
Elected by the shareholders, the Moderna's board of directors comprises two types of representatives: Moderna inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Moderna. The board's role is to monitor Moderna's management team and ensure that shareholders' interests are well served. Moderna's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Moderna's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marcello Damiani | Chief Digital and Operational Excellence Officer | Profile | |
| Shannon Klinger | Chief Sec | Profile | |
| James Mock | Chief Officer | Profile | |
| Lori Henderson | General Counsel, Company Secretary | Profile | |
| Tal Zaks | Chief Medical Officer | Profile | |
| John Reynders | Chief Officer | Profile |
Additional Information and Resources on Investing in Moderna Stock
When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Moderna Stock please use our How to Invest in Moderna guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.